Form D · Biotechnology
Lucid Diagnostics Inc.
New York, NY · CIK 0001799011
Offering snapshot reported Dec 6, 2024 · SEC filing
- Reported sold
- $22M Offering amount: $22M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 22, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 6, 2024 | Initial | $21,950,000 | No comparison | 7 | SEC filing |
| Nov 1, 2023 | Initial | $5,000,000 | No comparison | 2 | SEC filing |
| Apr 5, 2023 | Initial | $11,111,110 | No comparison | 1 | SEC filing |
| Mar 22, 2023 | Initial | $13,625,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-531401
Source: Form D, filed Dec 6, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lishan Aklog | Director, Executive |
| James L. Cox | Director |
| Michael A. Gordon | Executive |
| Stanley N. Lapidus | Director |
| Dennis A. Matheis | Director |
| Dennis M. Mcgrath | Executive |
| Dennis M Mc Grath | Executive |
| Shaun M. O'neil | Executive |
| Jacque J. Sokolov | Director |
| Ronald M. Sparks | Director |
| Debra J. White | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
360 Madison Avenue 25 Th Floor
New York, NY, 10017
New York, NY, 10017